Scott M Rocklage's Net Worth

$1.36 Million

Who is Scott M Rocklage?

Scott M Rocklage has an estimated net worth of $1.36 Million. This is based on reported shares across multiple companies, which include Skye Bioscience, Inc., Relypsa Inc, Crinetics Pharmaceuticals, Inc., Entrada Therapeutics, Inc., Pear Therapeutics, Inc., Pulmatrix, Inc., IDEAYA Biosciences, Inc., Rallybio Corp, ARVINAS INC., IMPEL NEUROPHARMA INC, Cidara Therapeutics, Inc., VIVEVE MEDICAL, INC., scPharmaceuticals Inc., Cabaletta Bio, Inc., Akouos, Inc., Homology Medicines, Inc., Aprea Therapeutics, Inc., Audentes Therapeutics, Inc., EPIRUS Biopharmaceuticals, Inc., PHASERX, INC., CUBIST PHARMACEUTICALS INC, and Achaogen Inc.

SEC CIK

Scott M Rocklage's CIK is 0001219014

Past Insider Trading and Trends

2004 was Scott M Rocklage's most active year for acquiring shares with 5 total transactions. Scott M Rocklage's most active month to acquire stocks was the month of May. 2004 was Scott M Rocklage's most active year for disposing of shares, totalling 57 transactions. Scott M Rocklage's most active month to dispose stocks was the month of February. 2004 saw Scott M Rocklage paying a total of $184,077.73 for 97,378 shares, this is the most they've acquired in one year. In 2004 Scott M Rocklage cashed out on 181,545 shares for a total of $1,233,488.95, their largest year based on trade value.